Fintel reports that on July 25, 2025, William Blair downgraded their outlook for Ameriprise Financial (NYSE:AMP) from ...

The company didn’t share specific data for the molecule, gefurulimab, but said it hit all endpoints in the Phase III PREVAIL ...

Fintel reports that on July 22, 2025, William Blair upgraded their outlook for Booz Allen Hamilton Holding (NYSE:BAH) from ...

William Blair analysts lowered their rating on Ameriprise stock to Market Perform from Outperform Friday following the financial services firm’s second-quarter report.

Palantir Technologies Inc. (NASDAQ:PLTR) is one of the best 52-week high stocks to buy now. On July 21, the stock was a big ...

Sarepta Therapeutics’ stock has dropped precipitously as questions swirl around the safety of its gene therapies. Meanwhile, ...

Five9's 2Q25 results are likely to beat consensus, while concerns regarding the substitution of human agents with AI are ...

Tesla (TSLA) is set to report second quarter earnings on Wednesday afternoon. William Blair group head of energy and power technologies sector Jed Dorsheimer joins Market Domination with Josh Lipton ...

A key driver of Tesla's profit is disappearing fast as the U.S. government changes policies on an environmental asset known ...

Sarepta would need to conduct new analyses to validate the safety of Elevidys—which has had U.S. shipments paused by the company over a mounting string of controversies—to the FDA, Endpoints News and ...

For years, Tesla has earned billions of dollars from its competitors just for selling electric vehicles. But that windfall is ...